Tirzepatide 10mg Pen vs 40mg MediT: Which Format Is Right?

The ORYN Tirzepatide Pen is a multi-dose pen system containing 10mg of tirzepatide in a 3mL cartridge, designed for daily precision dosing over 30 days:

Adjustable Dosing: The pen's dial mechanism allows researchers to set exact doses for each administration. This makes it ideal for dose-finding studies, gradual titration protocols, and research requiring precise dose-response data.

Daily Administration: Daily dosing provides more consistent compound levels and allows researchers to adjust doses in real-time based on observations.

30-Day Supply: A single pen provides a full month of daily dosing, with the flexibility to adjust the dose up or down throughout the protocol.

At €169, the Tirzepatide Pen offers the most affordable entry point for tirzepatide research with maximum control over the dosing protocol.

The ORYN MediT Pen is a prefilled, single-use injection pen containing 40mg of tirzepatide, designed for once-weekly administration:

Once-Weekly Dosing: The MediT Pen is engineered for weekly administration, aligning with the clinical usage pattern of tirzepatide in published research. This reduces the daily burden on research protocols.

Higher Total Dose: At 40mg per pen, the MediT delivers 4x the total tirzepatide of the standard pen. This supports higher-dose weekly protocols that mirror clinical trial designs.

Prefilled Convenience: No dose adjustment needed — each pen is ready to use with a fixed, predetermined dose. This eliminates dosing variability and simplifies multi-site research protocols.

At €249, the MediT Pen is the premium option for researchers who prioritise convenience and want to replicate clinical-style weekly dosing protocols.

Choose the Tirzepatide Pen (10mg, €169) if: - Your research requires dose titration or gradual escalation - You need to test multiple dose levels within a single protocol - Daily dosing is compatible with your research design - Budget is a consideration - You want maximum control over the dosing schedule

Choose the MediT Pen (40mg, €249) if: - Your protocol calls for weekly administration - You want to replicate clinical trial dosing patterns - Simplicity and convenience are priorities - You need a higher total dose per pen - Multiple researchers will administer (fixed dose reduces error)

Consider using both if: - Your research has a titration phase followed by a maintenance phase - You want to compare daily vs weekly dosing regimens - Different arms of your study require different dosing approaches